Editas Medicine

EDIT

EDIT
Editas Medicine Stock Quote
$30.04 $0.11 0.4%
BATS BZX Real Time Price as of January 22, 2020, 4:30 p.m. EST View Interactive EDIT Charts

Editas Medicine is a pioneer in gene editing technology. The biotech holds exclusive rights to CRISPR, a mechanism for cutting and pasting changes to DNA at precise locations.

News & Analysis: Editas Medicine

The Fool has written over 100 articles on Editas Medicine.

All

Market Moves

Earnings











Interactive Chart